Fund comparison · from official SEC filings
BIB vs LABU: how much do they overlap?
ProShares Ultra Nasdaq Biotechnology and Direxion Daily S&P Biotech Bull 3X Shares
Holdings overlap37%of assets, by weight Shared positions118of 259 / 154 holdings BIB expense ratio0.95%net, per year LABU expense ratio0.93%net, per year Shared holdings
G
GILDGILEAD SCIENCES INC
5.19%
0.79%
V
VRTXVERTEX PHARMACEUTICALS INC
5.18%
0.76%
A
AMGNAMGEN INC
4.99%
0.81%
R
REGNREGENERON PHARMACEUTICALS
3.57%
0.80%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.24%
0.85%
R
RVMDREVOLUTION MEDICINES INC
1.74%
1.27%
B
BIIBBIOGEN INC
1.61%
0.87%
U
UTHRUNITED THERAPEUTICS CORP
1.36%
0.92%
I
INSMINSMED INC
1.29%
0.86%
T
TVTXTRAVERE THERAPEUTICS INC
0.24%
1.25%
R
ROIVROIVANT SCIENCES LTD
1.20%
0.85%
A
ARWRARROWHEAD PHARMACEUTICALS IN
0.61%
1.11%
T
TWSTTWIST BIOSCIENCE CORP
0.23%
1.10%
S
SMMTSUMMIT THERAPEUTICS INC
0.76%
1.09%
I
INCYINCYTE CORP
1.08%
0.89%
A
ALKSALKERMES PLC
0.39%
1.07%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.64%
1.06%
M
MRNAMODERNA INC
1.04%
0.72%
B
BEAMBEAM THERAPEUTICS INC
0.19%
1.02%
A
APGEAPOGEE THERAPEUTICS INC
0.25%
0.98%
S
SRRKSCHOLAR ROCK HOLDING CORP
0.28%
0.95%
P
PRAXPRAXIS PRECISION MEDICINES I
0.54%
0.95%
E
EXELEXELIXIS INC
0.73%
0.94%
M
MIRMMIRUM PHARMACEUTICALS INC
0.34%
0.93%
Only in BIB
I
IQMMPROSHARES GENIUS MNY MKT ETF
7.57%
?
—Repurchase Agreement
3.50%
I
ILMNILLUMINA INC
1.39%
R
RPRXROYALTY PHARMA PLC- CL A
1.34%
A
ARGXARGENX SE - ADR
1.33%
V
VTRSVIATRIS INC
1.05%
G
GHGUARDANT HEALTH INC
0.95%
A
AGPXXINVESCO GVT & AGNCY-INST
0.90%
J
JAZZJAZZ PHARMACEUTICALS PLC
0.81%
A
ASNDASCENDIS PHARMA A/S
0.77%
M
MEDPMEDPACE HOLDINGS INC
0.71%
A
AXSMAXSOME THERAPEUTICS INC
0.67%
B
BNTXBIONTECH SE-ADR
0.61%
S
SNYSANOFI-ADR
0.60%
O
ONCBEONE MEDICINES LTD-ADR
0.51%
T
TEMTEMPUS AI INC-CL A
0.49%
A
ABVXABIVAX SA-ADR
0.46%
2
260CENTESSA PHARMACEUTICALS-ADR
0.27%
C
CAICARIS LIFE SCIENCES INC
0.26%
L
LGNDLIGAND PHARMACEUTICALS
0.26%
X
XENEXENON PHARMACEUTICALS INC
0.25%
I
INDVINDIVIOR PHARMACEUTICALS INC
0.25%
A
AMRXAMNEAL PHARMACEUTICALS INC
0.23%
N
NAMSNEWAMSTERDAM PHARMA CO NV
0.22%
Only in LABU
?
—DREYFUS GOVERNMENT CASH MANAGE
7.43%
?
—GOLDMAN SACHS LIQ ES FD A
1.71%
1
1JKAPELLIS PHARMACEUTICALS INC
1.44%
T
TGTXTG THERAPEUTICS INC
1.06%
N
NTRANATERA INC
0.92%
C
CELCCELCUITY INC
0.92%
6
6XCSOLENO THERAPEUTICS INC
0.82%
A
ABBVABBVIE INC
0.82%
V
VKTXVIKING THERAPEUTICS INC
0.77%
I
IMNMIMMUNOME INC
0.70%
?
—Catalyst Pharmaceuticals Inc.
0.66%
R
RCUSARCUS BIOSCIENCES INC
0.57%
D
DNTHDIANTHUS THERAPEUTICS INC
0.54%
C
CLDXCELLDEX THERAPEUTICS INC
0.42%
C
CAPRCAPRICOR THERAPEUTICS INC
0.41%
B
BHVNBIOHAVEN LTD
0.38%
V
VRDNVIRIDIAN THERAPEUTICS INC
0.37%
P
PVLAPALVELLA THERAPEUTICS INC
0.37%
C
CDNACAREDX INC
0.32%
S
SLSSELLAS LIFE SCIENCES GROUP I
0.24%
P
PURRHYPERLIQUID STRATEGIES
0.16%
E
EBSEMERGENT BIOSOLUTIONS INC
0.14%
V
VSTMVERASTEM INC
0.12%
Hold BIB and LABU together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Other comparisons you might like
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.